Overview Performance Dividends Peer Group Options

(MRAI) Marpai - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5713541093

MRAI: Care Management, Case Management, Actuary Services, Cost Containment

Marpai, Inc. (NASDAQ:MRAI) operates as a technology-driven healthcare payer, primarily serving the self-insured employer market in the United States and Israel. The company specializes in providing a range of ancillary services, including care management, case management, actuarial services, bill review, and cost containment solutions. Marpai, Inc. was incorporated in 2021 and is headquartered in Tampa, Florida.

The company leverages advanced data analytics and AI-driven tools to optimize healthcare spending and improve outcomes for its clients. Its services are designed to help employers manage healthcare costs more effectively while ensuring better care coordination for their employees. Marpai, Inc. has established operations in both the U.S. and Israel, reflecting its global approach to healthcare solutions.

Web URL: https://www.marpaihealth.com

Ticker Symbol: MRAI Exchange: NASDAQ Type: common stock Country Origin: United States GICS Sub Industry: Health Care Equipment Average Volume 20d: 5362 Last Price: 0.82 SMA 20: 0.92 SMA 50: 0.95 SMA 200: 0.85 ATR: 0.07 Market Cap: 12.93M USD P/E: 0.00 P/E Forward: 0.00 P/B: 1.49 P/S: 0.43 RoE: 94.19 3-Month Forecast: Based on and , MRAI is expected to face headwinds due to its current price trading below the SMA 20 and SMA 50. The low average volume and narrow ATR suggest limited market activity, which could lead to heightened volatility. However, the companys high RoE may indicate operational efficiency, potentially supporting stabilization efforts.

Additional Sources for MRAI Stock

News: Wall Street Journal Benzinga Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

MRAI Stock Overview

Market Cap in USD 16m
Sector Healthcare
Industry Healthcare Plans
GiC Sub-Industry Health Care Equipment
IPO / Inception 2021-10-27

MRAI Stock Ratings

Growth Rating -49.8
Fundamental 13.2
Dividend Rating 0.0
Rel. Strength -41.9
Analysts 4/5
Fair Price Momentum 0.96 USD
Fair Price DCF -

MRAI Dividends

No Dividends Paid

MRAI Growth Ratios

Growth Correlation 3m 54%
Growth Correlation 12m 40.3%
Growth Correlation 5y -86.9%
CAGR 5y -53.18%
CAGR/Max DD 5y -0.54
Sharpe Ratio 12m -0.02
Alpha -41.54
Beta -1.417
Volatility 98.05%
Current Volume 9.4k
Average Volume 20d 4.9k
What is the price of MRAI stocks?
As of May 10, 2025, the stock is trading at USD 1.30 with a total of 9,396 shares traded.
Over the past week, the price has changed by +23.81%, over one month by +44.44%, over three months by +30.00% and over the past year by -45.38%.
Is Marpai a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Marpai is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 13.20 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MRAI as of May 2025 is 0.96. This means that MRAI is currently overvalued and has a potential downside of -26.15%.
Is MRAI a buy, sell or hold?
Marpai has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy MRAI.
  • Strong Buy: 0
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecast for MRAI stock price target?
According to ValueRays Forecast Model, MRAI Marpai will be worth about 1 in May 2026. The stock is currently trading at 1.30. This means that the stock has a potential downside of -20%.
Issuer Forecast Upside
Wallstreet Target Price 6 361.5%
Analysts Target Price 12 823.1%
ValueRay Target Price 1 -20%